Expression of human fructose-1,6-bisphosphatase in the liver of transgenic mice results in increased glycerol gluconeogenesis

Endocrinology

Volumn 147, Issue 6, 2006, Pages 2764-2772

  Lamont, Benjamin J ^a   Visinoni, Sherley ^a   Fam, Barbara C ^a   Kebede, Melkam ^a   Weinrich, Blaise ^a   Papapostolou, Stavroula ^a   Massinet, Helene ^a   Proietto, Joseph ^a   Favaloro, Jenny ^a   Andrikopoulos, Sofianos ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE BISPHOSPHATASE; GLUCOSE; GLYCEROL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FBP1 GENE; GENE OVEREXPRESSION; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BLOOD GLUCOSE; FEMALE; FRUCTOSE-BISPHOSPHATASE; GLUCONEOGENESIS; GLYCEROL; HUMANS; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP);

EID: 33646763166     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-1498     Document Type: Article

References (62)

1. Boden G, Chen X, Stein TP 2001 Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 280:E23-E30
2. Radziuk J, Pye S 2001 Production and metabolic clearance of glucose under basal conditions in Type II (non-insulin-dependent) diabetes mellitus. Diabetologia 44:983-991
3. Magnusson I, Rothman DL, Katz LD, Shulman RG, Shulman GI 1992 Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest 90:1323-1327
4. Jeng CY, Sheu WH, Fuh MM, Chen YD, Reaven GM 1994 Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM. Diabetes 43:1440-1444
5. Gastaldelli A, Baldi S, Pettiti M, Toschi E, Camastra S, Natali A, Landau BR, Ferrannini E 2000 Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 49:1367-1373
6. Perriello G, Pampanelli S, Del Sindaco P, Lalli C, Ciofetta M, Volpi E, Santeusanio F, Brunetti P, Bolli GB 1997 Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes 46:1010-1016
7. Basu R, Schwenk WF, Rizza RA 2004 Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes. Am J Physiol Endocrinol Metab 287:E55-E62
8. Firth RG, Bell PM, Marsh HM, Hansen I, Rizza RA 1986 Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues. J Clin Invest 77:1525-1532
9. Ferrannini E, Simonson DC, Katz LD, Reichard Jr G, Bevilacqua S, Barrett EJ, Olsson M, DeFronzo RA 1988 The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. Metabolism 37:79-85
10. Kelley D, Mokan M, Veneman T 1994 Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus. Metabolism 43:1549-1557
11. Mitrakou A, Kelley D, Veneman T, Jenssen T, Pangburn T, Reilly J, Gerich J 1990 Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes 39:1381-1390
12. Singhal P, Caumo A, Carey PE, Cobelli C, Taylor R 2002 Regulation of endogenous glucose production after a mixed meal in type 2 diabetes. Am J Physiol Endocrinol Metab 283:E275-E283
13. Roden M, Bernroider E 2003 Hepatic glucose metabolism in humans - its role in health and disease. Best Pract Res Clin Endocrinol Metab 17:365-383
14. Cersosimo E, Ajmal M, Naukam RJ, Molina PE, Abumrad NN 1997 Role of the kidney in plasma glucose regulation during hyperglycemia. Am J Physiol 272:E756-E761
15. Meyer C, Stumvoll M, Nadkarni V, Dostou J, Mitrakou A, Gerich J 1998 Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. J Clin Invest 102:619-624
16. Stumvoll M, Meyer C, Mitrakou A, Nadkarni V, Gerich JE 1997 Renal glucose production and utilization: new aspects in humans. Diabetologia 40:749-757
17. Hundal RS, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V, Inzucchi SE, Schumann WC, Petersen KF, Landau BR, Shulman GI 2000 Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49:2063-2069
18. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS 2003 Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76-79
19. Boden G, Jadali F 1991 Effects of lipid on basal carbohydrate metabolism in normal men. Diabetes 40:686-692
20. Clore JN, Glickman PS, Nestler JE, Blackard WG 1991 In vivo evidence for hepatic autoregulation during FFA-stimulated gluconeogenesis in normal humans. Am J Physiol 261:E425-E429
21. Roden M, Stingl H, Chandramouli V, Schumann WC, Hofer A, Landau BR, Nowotny P, Waldhausl W, Shulman GI 2000 Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes 49:701-707
22. Saloranta C, Franssila-Kallunki A, Ekstrand A, Taskinen MR, Groop L 1991 Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34:409-415
23. Staehr P, Hother-Nielsen O, Landau BR, Chandramouli V, Holst JJ, Beck-Nielsen H 2003 Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis. Diabetes 52:260-267
24. Puhakainen I, Koivisto VA, Yki-Jarvinen H 1991 No reduction in total hepatic glucose output by inhibition of gluconeogenesis with ethanol in NIDDM patients. Diabetes 40:1319-1327
25. Puhakainen I, Yki-Jarvinen H 1993 Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM. Diabetes 42:1694-1699
26. Carlson CW, Baxter RC, Ulm EH, Pogell BM 1973 Role of oleate in the regulation of "neutral" rabbit liver fructose 1,6-diphosphatase activity. J Biol Chem 248:5555-5561
27. Andrikopoulos S, Proietto J 1995 The biochemical basis of increased hepatic glucose production in a mouse model of type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 38:1389-1396
28. Song S, Andrikopoulos S, Filippis C, Thorburn AW, Khan D, Proietto J 2001 Mechanism of fat-induced hepatic gluconeogenesis: effect of metformin. Am J Physiol Endocrinol Metab 281:E275-E282
29. Antras-Ferry J, Le Bigot G, Robin P, Robin D, Forest C 1994 Stimulation of phosphoenolpyruvate carboxykinase gene expression by fatty acids. Biochem Biophys Res Commun 203:385-391
30. Massillon D, Barzilai N, Hawkins M, Prus-Wertheimer D, Rossetti L 1997 Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion. Diabetes 46:153-157
31. Arizmendi C, Liu S, Croniger C, Poli V, Friedman JE 1999 The transcription factor CCAAT/enhancer-binding protein beta regulates gluconeogenesis and phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes. J Biol Chem 274:13033-13040
32. Friedman JE, Yun JS, Patel YM, McGrane MM, Hanson RW 1993 Glucocorticoids regulate the induction of phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes. J Biol Chem 268:12952-12957
33. Trinh KY, O'Doherty RM, Anderson P, Lange AJ, Newgard CB 1998 Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats. J Biol Chem 273:31615-31620
34. Chang AY, Schneider DI 1970 Abnormalities in hepatic enzyme activities during development of diabetes in db mice. Diabetologia 6:274-278
35. Seidman I, Horland AA, Teebor GW 1967 Hepatic glycolytic and gluconeogenic enzymes of the obese-hyperglycemic mouse. Biochim Biophys Acta 146:600-603
36. Seidman I, Horland AA, Teebor GW 1970 Glycolytic and gluconeogenic enzyme activities in the hereditary obese-hyperglycemic syndrome and in acquired obesity. Diabetologia 6:313-316
37. Taketomi S, Ishikawa E, Iwatsuka H 1975 Lipogenic enzymes in two types of genetically obese animals, fatty rats and Yellow KK mice. Horm Metab Res 7:242-246
38. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, Kahn CR 2000 Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87-97
39. Kabir M, Catalano KJ, Ananthnarayan S, Kim SP, Van Citters GW, Dea MK, Bergman RN 2005 Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab 288:E454-E461
40. Valera A, Pujol A, Pelegrin M, Bosch F 1994 Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 91:9151-9154
41. Sun Y, Liu S, Ferguson S, Wang L, Klepcyk P, Yun JS, Friedman JE 2002 Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice. J Biol Chem 277:23301-23307
42. Rosella G, Zajac JD, Baker L, Kaczmarczyk SJ, Andrikopoulos S, Adams TE, Proietto J 1995 Impaired glucose tolerance and increased weight gain in transgenic rats overexpressing a non-insulin-responsive phosphoenolpyruvate carboxykinase gene. Mol Endocrinol 9:1396-1404
43. Lamont BJ, Andrikopoulos S, Funkat A, Favaloro J, Ye JM, Kraegen EW, Howlett KF, Zajac JD, Proietto J 2003 Peripheral insulin resistance develops in transgenic rats overexpressing phosphoenolpyruvate carboxykinase in the kidney. Diabetologia 46:1338-1347
44. Puhakainen I, Koivisto VA, Yki-Jarvinen H 1992 Lipolysis and gluconeogenesis from glycerol are increased in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 75:789-794
45. Nurjhan N, Consoli A, Gerich J 1992 Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus. J Clin Invest 89:169-175
46. Wu H, Wade M, Krall L, Grisham J, Xiong Y, Van Dyke T 1996 Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration. Genes Dev 10:245-260
47. Andrikopoulos S, Rosella G, Gaskin E, Thorburn A, Kaczmarczyk S, Zajac JD, Proietto J 1993 Impaired regulation of hepatic fructose-1,6-bisphosphatase in the New Zealand obese mouse model of NIDDM. Diabetes 42:1731-1736
48. Andrikopoulos S, Rosella G, Kaczmarczyk SJ, Zajac JD, Proietto J 1996 Impaired regulation of hepatic fructose-1,6-biphosphatase in the New Zealand Obese mouse: an acquired defect. Metabolism 45:622-626
49. Andrikopoulos S, Verchere CB, Terauchi Y, Kadowaki T, Kahn SE 2000 β-Cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes. Diabetes 49:2056-2062
50. Kooptiwut S, Zraika S, Thorburn AW, Dunlop ME, Darwiche R, Kay TW, Proietto J, Andrikopoulos S 2002 Comparison of insulin secretory function in two mouse models with different susceptibility to β-cell failure. Endocrinology 143:2085-2092
51. Nolan CJ, Proietto J 1994 The feto-placental glucose steal phenomenon is a major cause of maternal metabolic adaptation during late pregnancy in the rat. Diabetologia 37:976-984
52. Jamieson E, Chong MM, Steinberg GR, Jovanovska V, Fam BC, Bullen DV, Chen Y, Kemp BE, Proietto J, Kay TW, Andrikopoulos S 2005 Socs1 deficiency enhances hepatic insulin signaling. J Biol Chem 280:31516-31521
53. Eggstein M, Kuhlmann E 1974 Triglycerides and glycerol. In: Bergmeyer HU, ed. Methods in enzymology. New York: Academic Press; 1825-1831
54. Kunst A, Draeger D, Ziegenhorh N 1974 D-Glucose. In: Bergmeyer HU, ed. Methods in enzymology. New York: Academic Press; 163-172
55. Funkat A, Massa CM, Jovanovska V, Proietto J, Andrikopoulos S 2004 Metabolic adaptations of three inbred strains of mice (C57BL/6, DBA/2, and 129T2) in response to a high-fat diet. J Nutr 134:3264-3269
56. Wajngot A, Chandramouli V, Schumann WC, Ekberg K, Jones PK, Efendic S, Landau BR 2001 Quantitative contributions of gluconeogenesis to glucose production during fasting in type 2 diabetes mellitus. Metabolism 50:47-52
57. Veroni MC, Proietto J, Larkins RG 1991 Evolution of insulin resistance in New Zealand obese mice. Diabetes 40:1480-1487
58. Proietto J, Andrikopoulos S 2004 Molecular mechanisms of increased glucose production: identifying potential therapeutic targets. J Investig Med 52:389-393
59. Erion MD, van Poelje PD, Dang Q, Kasibhatla SR, Potter SC, Reddy MR, Reddy KR, Jiang T, Lipscomb WN 2005 MB06322 (CS-917): a potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes. Proc Natl Acad Sci USA 102:7970-7975
60. Lam TK, Carpentier A, Lewis GF, van de Werve G, Fantus IG, Giacca A 2003 Mechanisms of the free fatty acid-induced increase in hepatic glucose production. Am J Physiol Endocrinol Metab 284:E863-E873
61. Rosella G, Zajac JD, Kaczmarczyk SJ, Andrikopoulos S, Proietto J 1993 Impaired suppression of gluconeogenesis induced by overexpression of a noninsulin-responsive phosphoenolpyruvate carboxykinase gene. Mol Endocrinol 7:1456-1462
62. She P, Shiota M, Shelton KD, Chalkley R, Postic C, Magnuson MA 2000 Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism. Mol Cell Biol 20:6508-6517